• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Fibralign

Fibralign wins CE mark for BioBridge tissue repair device

September 15, 2020 By Sean Whooley

Stanford spin-out Fibralign announced that it received CE Mark approval in Europe for its BioBridge collagen matrix. Union City, Calif.-based Fibralign’s BioBridge has been designated as a Class III device with an indication for use in supporting lymphatic tissue repair and can be used after or in conjunction with surgical procedures addressing lymphedema, according to […]

Filed Under: Regenerative Medicine, Regulatory/Compliance Tagged With: CE Mark, Fibralign

Fibralign partners with Terumo

June 2, 2020 By Sean Whooley

Stanford spin-out Fibralign announced today that it entered into a long-term distributor agreement with Terumo for the BioBridge collagen matrix. The agreement is set to see Terumo market and distribute BioBridge collagen matrix, which is used to treat and prevent secondary lymphedema, in Japan. BioBridge is a sterile, implantable, biocompatible and biodegradable surgical mesh made […]

Filed Under: Business/Financial News, Distribution, Regenerative Medicine Tagged With: Fibralign, Terumo

Fibralign closes syndicate funding round from AngelMD

November 29, 2017 By Fink Densford

Fibralign has recently closed a syndicate funding round coordinated by investment and networking platform AngelMD to support its Nanoweave 3D scaffolding tech and medical devices using the technology. The Union City, Calif.-based company’s first product is the BioBridge collagen matrix, which is an implantable, biocompatible and biodegradable surgical mesh with 510(k) clearance for use in […]

Filed Under: Business/Financial News, Regenerative Medicine Tagged With: Fibralign

Stanford launches independent study of Fibralign’s BioBridge

September 2, 2016 By Fink Densford

Stanford University has begun enrollment in an investigator-led clinical study of Fibralign‘s BioBridge collagen matrix designed for treating secondary lymphedema, the company said yesterday. The BioBridge collagen matrix is an implantable, biocompatible and biodegradable surgical mesh with 510(k) clearance for use in surgery to “reinforce and repair soft tissue where weakness and deficiencies exist,” the company said, […]

Filed Under: Clinical Trials, Regenerative Medicine Tagged With: Fibralign, Stanford University

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS